Korean pharmaceutical firms seeking to acquire promising bioventure companies

Domestic drug makers are focusing on investment or acquisition for promising biopharmaceutical companies with platform technologies as part of efforts to survive in an era of free trade deals with foreign countries.

Local pharmaceutical companies have been largely dependent on producing and marketing generic drugs instead of inventing new drugs.

“We can no longer depend on sales of generi...